hex

Additional Senior Leadership Team Members

Scott Dove

Scott Dove, Ph.D.

Senior Vice President and Global Head, Early Development Services

Scott Dove, Ph.D., serves as senior vice president and global head of early development services for PPD, providing strategic direction and oversight of early development clinical research units and dedicated early-phase CRO services.

Dr. Dove rejoined PPD in 2017 as vice president and global head of early development services after having previously served with PPD for 10 years in a variety of product development, compound partnering and medical writing leadership positions. In between, he spent five years with Furiex Pharmaceuticals, an independent company spun out from PPD’s compound partnering division, prior to its acquisition by Actavis (now Allergan). Immediately before returning to PPD, Dr. Dove served as executive director of clinical development in gastroenterology for Allergan. He has more than 20 years of drug development experience.

Dr. Dove earned a doctorate in pharmacology and a Bachelor of Science in biochemistry, both from Texas A&M University.